These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35649148)

  • 1. In-silico efficacy of potential phytomolecules from Ayurvedic herbs as an adjuvant therapy in management of COVID-19.
    Kumar B; Misra A; Singh SP; Dhar YV; Rawat P; Chattopadhyay D; Barik SK; Srivastava S
    J Food Drug Anal; 2021 Dec; 29(4):559-580. PubMed ID: 35649148
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
    Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
    Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.
    Borse S; Joshi M; Saggam A; Bhat V; Walia S; Marathe A; Sagar S; Chavan-Gautam P; Girme A; Hingorani L; Tillu G
    PLoS One; 2021; 16(6):e0248479. PubMed ID: 34115763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies.
    Kumar Verma A; Kumar V; Singh S; Goswami BC; Camps I; Sekar A; Yoon S; Lee KW
    Biomed Pharmacother; 2021 May; 137():111356. PubMed ID: 33561649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
    Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.
    Bondhon TA; Fatima A; Jannat K; Hasan A; Jahan R; Nissapatorn V; Wiart C; Pereira ML; Rahmatullah M
    Trop Biomed; 2021 Jun; 38(2):214-221. PubMed ID: 34172713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin.
    Kumari A; Rajput VS; Nagpal P; Kukrety H; Grover S; Grover A
    J Biomol Struct Dyn; 2022 Jul; 40(11):4987-4999. PubMed ID: 33357073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using
    Rasul HO; Thomas NV; Ghafour DD; Aziz BK; Salgado M G; Mendoza-Huizar LH; Candia LG
    J Biomol Struct Dyn; 2024 May; 42(8):4234-4248. PubMed ID: 37349945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.
    Hall DC; Ji HF
    Travel Med Infect Dis; 2020; 35():101646. PubMed ID: 32294562
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.
    Jalalvand A; Khatouni SB; Najafi ZB; Fatahinia F; Ismailzadeh N; Farahmand B
    J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):85-95. PubMed ID: 34265888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective.
    Abosheasha MA; El-Gowily AH; Elfiky AA
    J Thromb Thrombolysis; 2022 Feb; 53(2):273-281. PubMed ID: 34510337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.
    Maikhunthod B; Chaipayang S; Jittmittraphap A; Thippornchai N; Boonchuen P; Tittabutr P; Eumkeb G; Sabuakham S; Rungrotmongkol T; Mahalapbutr P; Leaungwutiwong P; Teaumroong N; Tanthanuch W
    BMC Complement Med Ther; 2024 Jul; 24(1):274. PubMed ID: 39030504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M
    Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F
    Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19.
    Mujwar S; Sun L; Fidan O
    J Food Biochem; 2022 Sep; 46(9):e14219. PubMed ID: 35545850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.